LONDON: Oncimmune Holdings announced the award of funding from the ‘UK Research and Innovation (UKRI) Ideas to Address COVID-19’ programme, to support a joint collaboration between Oncimmune and Medicines Discovery Catapult to deliver the IMmunity Profiling of pAtients with COVID-19 for Therapy and Triage (IMPACTT) programme. This collaboration represents a critical partnership in response to…